Boehringer Ingelheim and Lilly provide update on Jardiance® phase III exercise ability studies in chronic heart failure | Small Molecules | News Channels - PipelineReview.com

Boehringer Ingelheim and Lilly provide update on Jardiance® phase III exercise ability studies in chronic heart failure | Small Molecules | News Channels  PipelineReview.com